Intravesical oxybutynin for bladder capacity in children with spina bifida: the ‘Place de l’OXybutynine Intravésicale chez le Patient Enfant Neurologique’ ( <scp>POXIPEN)</scp> trial protocol
This trial is registered with the European Union (EU) Clinical Trials Information System (CTIS) under EU CT Number: 2022-501 902-36-00 (approved 09.01.2025) and ClinicalTrials.gov under identifier NCT07027020 (registered 18.06.2025).
Authors
- Nicolas Berte (ORCID: https://orcid.org/0000-0002-6740-3897)
- Marie Buzzi (ORCID: https://orcid.org/0000-0003-3002-6976)
- Nadine Juge
- Charles Mazeaud (ORCID: https://orcid.org/0000-0002-7717-0986)
- Jean‐Louis Lemelle (ORCID: https://orcid.org/0000-0001-6438-2448)
- Jonathan Epstein (ORCID: https://orcid.org/0000-0001-7908-7636)
- Zahi Hatem
Institutions
- Inserm (FR)
- Interdisciplinarité en Santé Publique Interventions et Instruments de mesure complexes – Région Est (FR)
- Université de Lorraine (FR)
Publication Details
- Journal
- British Journal of Urology
- Published
- 2025-11-03
- DOI
- https://doi.org/10.1111/bju.70058
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00